Serratiopeptidase-induced bleeding in a Behçet's patient.
Journal name: World Journal of Pharmaceutical Research
Original article title: A case report on serratiopeptidase induced internal bleeding in a patient with behçet's illness
The WJPR includes peer-reviewed publications such as scientific research papers, reports, review articles, company news, thesis reports and case studies in areas of Biology, Pharmaceutical industries and Chemical technology while incorporating ancient fields of knowledge such combining Ayurveda with scientific data.
This page presents a generated summary with additional references; See source (below) for actual content.
Original source:
This page is merely a summary which is automatically generated hence you should visit the source to read the original article which includes the author, publication date, notes and references.
Dr. P. Venkata Ramana, Thumpera Aravind, S. Ayesha, A. Jayasree and C. T. Anjana Devi
Download the PDF file of the original publication
World Journal of Pharmaceutical Research:
(An ISO 9001:2015 Certified International Journal)
Full text available for: A case report on serratiopeptidase induced internal bleeding in a patient with behçet's illness
Source type: An International Peer Reviewed Journal for Pharmaceutical and Medical and Scientific Research
Doi: 10.20959/wjpr20172-7671
Copyright (license): WJPR: All rights reserved
Summary of article contents:
Introduction
Serratiopeptidase, a proteolytic enzyme derived from the enterobacterium Serratia species found in silkworm intestines, is known for its ability to purify products of inflammation and reduce edema. It is often used in various medical contexts, particularly for its purported benefits in controlling thrombosis and inflammation. This case report focuses on a 28-year-old Syrian woman diagnosed with Behçet's Disease, who experienced severe ecchymosis as a result of her uncontrolled use of Serratiopeptidase.
Serratiopeptidase and Its Implications
Serratiopeptidase possesses properties that potentially help in the management of inflammatory conditions by breaking down proteins associated with inflammation, such as fibrin. However, while it can aid in preventing swelling and fluid retention, its association with increased bleeding risk is significant, especially when combined with other substances like garlic or fish oil. The patient in the case report had been prescribed Serratiopeptidase to manage symptoms associated with Behçet's Disease, including edema following a history of venous thrombosis. This context highlights the need for careful monitoring when using such proteolytic agents.
Behçet's Disease and Its Complications
Behçet’s Disease is a complex, multisystemic inflammatory condition characterized by recurrent oral and genital ulcers and uveitis. The disease can lead to serious vascular complications, including venous thrombosis, which is often mediated by endothelial inflammation rather than traditional anticoagulation therapies. The report describes how these vascular manifestations can complicate the management of the disease, complicating treatment strategies aimed at preventing thrombosis while managing inflammation.
Bleeding Risks Associated with Proteolytic Enzymes
In this case study, the patient presented with diffuse ecchymotic hemorrhage, which is considered extremely rare in the context of Behçet's Disease. The simultaneous use of Serratiopeptidase contributed to a significant deterioration in her coagulation parameters, leading to increased bleeding risk, thereby necessitating treatment interventions such as fresh frozen plasma and vitamin K to address the hemorrhage. This situation underscores the critical need for awareness of potential bleeding risks when using proteolytic enzymes in patients with underlying vascular disease.
Conclusion
The interplay between managing vascular thrombosis in Behçet's Disease and the risks associated with proteolytic enzymes like Serratiopeptidase is crucial for patient safety. Given the inherent risks of bleeding when using anticoagulants or proteolytic therapy, healthcare providers must carefully evaluate the benefits and risks of these treatments. This case serves as a reminder of the complexities involved in managing multifaceted diseases and the importance of individualized patient care, especially regarding medication management in patients with increased bleeding risks.
FAQ section (important questions/answers):
What is Serratiopeptidase and its primary function?
Serratiopeptidase is a proteolytic enzyme from the Serratia species. Its primary function is to purify inflammatory products and eliminate substances like pus, cysts, blood clots, and scar tissue.
What is Behçet's Disease and its common symptoms?
Behçet's Disease is a chronic inflammatory condition characterized by recurring oral and genital ulcers, uveitis, and can involve various systemic manifestations including joint pain and vascular complications.
What were the symptoms observed in the patient described in the case report?
The 28-year-old female patient exhibited multiple ecchymotic foci on her body, indicating diffuse ecchymotic hemorrhage, which developed within 24 hours and was associated with her Behçet's Disease.
What treatment was the patient receiving for her condition?
The patient was receiving a combination of medications, including azathioprine, omeprazole, and Serratiopeptidase, aimed at managing Behçet’s Disease and preventing further venous thrombosis.
Why is anticoagulation not recommended in Behçet's Disease management?
Anticoagulants and antiplatelet drugs are not recommended due to the high risk of bleeding, which is especially pertinent for patients with Behçet's Disease experiencing vascular thrombosis.
How was the patient's diffuse ecchymotic hemorrhage treated?
The bleeding was managed by administering fresh frozen plasma and vitamin K, which helped normalize coagulation parameters, and the patient's ecchymosis resolved during follow-up.
Glossary definitions and references:
Scientific and Ayurvedic Glossary list for “Serratiopeptidase-induced bleeding in a Behçet's patient.”. This list explains important keywords that occur in this article and links it to the glossary for a better understanding of that concept in the context of Ayurveda and other topics.
1) Disease:
Disease refers to an abnormal condition affecting the body, often characterized by specific symptoms and signs. In this case report, Behçet's disease is highlighted as a multi systemic chronic inflammatory disease associated with vascular complications, such as thrombosis. Understanding the disease's impact is crucial for managing patients effectively.
2) Bleeding:
Bleeding is the loss of blood from the circulatory system, which can be a serious medical condition. In this case, the patient experienced diffuse ecchymotic hemorrhage linked to Serratiopeptidase use alongside Behçet's disease. Awareness of bleeding risks is essential when prescribing medications, especially those affecting hemostasis.
3) Drug:
A drug is a substance intended for use in the diagnosis, treatment, or prevention of disease. Serratiopeptidase, as discussed in this report, is used for its proteolytic properties to manage swelling and edema but comes with potential risks, like increased bleeding, emphasizing the need for careful assessment of medication effects.
4) Venkata (Vemkata):
Venkata refers to Dr. P. Venkata Ramana, the corresponding author of the case report. His work illustrates the clinical implications of using Serratiopeptidase in treating a patient with Behçet's disease. The authorship adds credibility to the findings, as it reflects expertise in pharmacy practice and patient management.
5) Ulcer:
An ulcer is a sore on the skin or a mucous membrane characterized by the loss of epithelial tissue. In Behçet's disease, recurrent oral and genital ulcers are significant manifestations. Understanding ulcer formation and management is crucial for treating patients who suffer from this chronic inflammatory condition.
6) Blood:
Blood is the fluid that circulates through the cardiovascular system, supplying oxygen and nutrients while removing waste products. In this context, the patient's blood analysis helped confirm the presence of diffuse hemorrhage and rule out other complications, illustrating the importance of blood tests in assessing patient health.
7) Inflammation:
Inflammation is the body's response to injury or infection, characterized by redness, heat, swelling, and pain. In Behçet's disease, systemic inflammation can contribute to thrombotic tendencies and complications. Understanding how inflammation influences vascular issues is critical in developing appropriate treatment strategies for affected patients.
8) Species:
Species in this context refers to the specific classification of organisms, particularly the Serratia species from which Serratiopeptidase is derived. Recognizing the origin and properties of drugs is important for understanding their mechanisms, applications, and potential side effects in clinical settings.
9) Edema (Oedema):
Edema is the abnormal accumulation of fluid in the interstitial spaces, often leading to swelling. The case report discusses the patient's leg edema associated with venous thrombosis and the preventative use of Serratiopeptidase, highlighting the need for effective management of edema in chronic inflammatory diseases.
10) Kadapa:
Kadapa is a city in India where the authors of the report are affiliated with P.Rami Reddy Memorial College of Pharmacy. Understanding the geographic context establishes the setting for case reporting and highlights the diverse patient population that may present with complex diseases like Behçet's.
11) Rami:
Rami refers to P.Rami Reddy Memorial College of Pharmacy, the institution where the authors conduct their research. This affiliation enriches the case report's credibility and underscores the importance of academic institutions in advancing pharmaceutical and clinical knowledge through collaborative research efforts.
12) Surface:
Surface refers to the exterior layer or area of an object or organism. In this case, the patient's ecchymotic foci were observed on her body's surface. Documenting visible symptoms is critical in clinical assessment and diagnosis, supporting the understanding of disease manifestations like hemorrhage.
13) Syria (Syrian):
Syrian denotes the nationality of the patient, providing context for the specific case reported. Recognizing the patient's background may also address demographic factors relevant to the occurrence and management of Behçet's disease, which can vary based on genetic, environmental, and social factors.
14) Fish oil:
Fish oil, rich in omega-3 fatty acids, is commonly used for its anti-inflammatory properties. In this report, the interaction of Serratiopeptidase and fish oil highlights the importance of recognizing dietary supplements that may increase bleeding risk when used alongside proteolytic enzymes or anticoagulants.
15) Discussion:
Discussion refers to the section of the report that interprets findings and provides a narrative around the case details. It is crucial for drawing conclusions about the clinical implications of the case, including insights into the interaction between Serratiopeptidase, Behçet's disease, and bleeding tendencies.
16) Turmeric:
Turmeric is a spice known for its anti-inflammatory and antioxidant properties, which can also influence bleeding risk when taken with certain medications. The mention of turmeric in this document emphasizes the need for careful consideration of herbal supplements in patients being treated for high-risk conditions like thrombosis.
17) Swelling:
Swelling is a common symptom of inflammation, characterized by fluid accumulation. In the case report, swelling was associated with lower extremity edema after venous thrombosis, making it significant for understanding patient symptoms and guiding appropriate therapeutic interventions in inflammatory diseases.
18) Anjana (Amjana):
Anjana refers to C. T. Anjana Devi, one of the authors of the case report. Her involvement, along with the other authors, signifies collaboration in academic research, reflecting contributions from multiple professionals in addressing complex medical cases in pharmacy practice.
19) Nausea:
Nausea is the sensation of needing to vomit, often a side effect of various medications. In relation to Serratiopeptidase, being aware of potential side effects like nausea is necessary for providing comprehensive patient care and managing expectations regarding treatment outcomes.
20) Garlic:
Garlic, recognized for its medicinal properties, can also increase the risk of bleeding when combined with medications like Serratiopeptidase. Awareness of how garlic and other supplements interact with prescribed drugs is essential for clinicians to ensure patient safety and minimize complications.
21) Study (Studying):
Study refers to research efforts aimed at gathering and analyzing data to advance knowledge about a topic. The case report contributes to the broader understanding of Behçet's disease and associated treatments, emphasizing the critical nature of ongoing research in improving clinical outcomes for affected patients.
22) Devi:
Devi refers to C. T. Anjana Devi, one of the authors of the case report. Her name represents the collaborative effort among the authors to document the clinical findings and implications related to Serratiopeptidase use in patients with Behçet's disease, enhancing the report's authority.
23) Fish:
Fish, particularly in regards to fish oil, holds significance for its beneficial omega-3 fatty acids which can improve overall health. However, fish oil use should be monitored due to its potential interaction with anticoagulant therapies, underscoring the need for careful dietary recommendations for patients.
24) Pur:
Poor in this context refers to a lack of effectiveness or unfavorable outcomes, especially regarding the prognosis of patients with vascular issues. Poor management of conditions like venous thrombosis in Behçet's disease emphasizes the need for tailored treatment strategies to improve patient health and safety.
Other Science Concepts:
Discover the significance of concepts within the article: ‘Serratiopeptidase-induced bleeding in a Behçet's patient.’. Further sources in the context of Science might help you critically compare this page with similair documents:
Medical history, Physical examination, Clinical trial, Thrombophlebitis, Anticoagulant, Chemical properties, Systemic inflammation, Antiplatelet agent, Venous thrombosis, Vascular thrombosis, Laboratory examination, Antifibrinolytic agent.